[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Mehta et al., 2000 - Google Patents

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

Mehta et al., 2000

Document ID
14258240796558504975
Author
Mehta S
Brancati F
Sulkowski M
Strathdee S
Szklo M
Thomas D
Publication year
Publication venue
Annals of internal medicine

External Links

Snippet

Background: Hepatitis C virus (HCV) infection may contribute to the development of diabetes mellitus. This relationship has not been investigated at the population level, and its biological mechanism remains unknown. Objective: To examine the prevalence of type 2 …
Continue reading at www.acpjournals.org (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/576Immunoassay; Biospecific binding assay for hepatitis
    • G01N33/5767Immunoassay; Biospecific binding assay for hepatitis non-A, non-B hepatitis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/36Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references

Similar Documents

Publication Publication Date Title
Mehta et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States
Eslam et al. Meta‐analysis: insulin resistance and sustained virological response in hepatitis C
Imazeki et al. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus‐infected and hepatitis C virus‐cleared patients
Alberti et al. Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection
Veldt et al. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis
Seeff et al. 45-year follow-up of hepatitis C virus infection in healthy young adults
Kalantar-Zadeh et al. Hepatitis C virus and death risk in hemodialysis patients
Sulkowski et al. Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus
Fabrizi et al. Post‐transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta‐analysis of clinical studies
Dalton et al. The role of hepatitis E virus testing in drug‐induced liver injury
Koretz et al. Non-A, non-B post-transfusion hepatitis: looking back in the second decade
Liu et al. Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
Mallet et al. Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C
Stepanova et al. Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity
Giordanino et al. Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study
Huang et al. Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link?
Brown et al. Hepatitis B-associated fibrosis and fibrosis/cirrhosis regression with nucleoside and nucleotide analogs
Pojoga et al. Impaired health-related quality of life in Romanian patients with chronic viral hepatitis before antiviral therapy
Huang et al. Reappraisal of the characteristics of glucose abnormalities in patients with chronic hepatitis C infection
Mehta et al. Association between hepatitis C virus infection and diabetes mellitus
Shiffman et al. Treatment of chronic hepatitis C virus in African Americans with genotypes 2 and 3
van Kleef et al. Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study
Huang et al. Pegylated interferon plus ribavirin therapy improves pancreatic β‐cell function in chronic hepatitis C patients
Kuchay et al. Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes
Hallager et al. Mortality in patients with Chronic Hepatitis C and cirrhosis compared to the general population–a Danish cohort study